| Ytd | -63.07% | |
| 1y | -59.43% |
| Open | 0.30 | Prev Close | 0.36 | Low | 0.28 | High | 0.33 | Mkt Cap | 3.73M |
| Vol | 878.13K | Avg Vol | 1.32M | EPS | -3.85 | P/E | -0.09 | Forward P/E | -0.87 |
| Beta | N/A | Short Ratio | 0.43 | Inst. Own | 23.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-05 | Earning | 08-27 | 50-d Avg | 0.53 | 200-d Avg | 0.75 | 1yr Est | 3.00 |
TRIB News
Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#
DUBLIN, July 22, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), (the “Company”) today
- Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose
- Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech's CGM+ 's purpose-bu
Gainers Alzamend Neuro (NASDAQ:ALZN) stock increased by 12.9% to $1.35 during Tuesday's after-m
- Milestone an important step in launching Trinovium within the global AI data center ecosystem- Dat
- Milestone an important step in launching Trinovium within the global AI data center ecosystem - Da
Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market
Trinity Biotech plc (NASDAQ:TRIB), a commercial stage biotechnology company focused on human diagnos
DUBLIN, June 29, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage bio
Gainers Aditxt (NASDAQ:ADTX) shares increased by 151.6% to $0.05 during Tuesday's regular sessi
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi
- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertis
- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertis
– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and prof
- Appointment supports revenue quality and profitability momentum as the Company activates its trans
Kyverna Therapeutics Inc (NASDAQ: KYTX) shares rose 25.8% in pre-market trading after positive trial
Trinity Biotech (NASDAQ: TRIB - Get Free Report) is expected to release its Q4 2025 resultson Wednes
DUBLIN and NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a global
Trinity Biotech (NASDAQ: TRIB - Get Free Report) and CompuMed (OTCMKTS:CMPD - Get Free Report) are b
DUBLIN and NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commer
Company begins roll out of innovative diabetes care HbA1c column system in Brazil Commercial leader
DUBLIN and WILSONVILLE, Ore., March 11, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB),
- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commer
DUBLIN, March 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage bi
Ayr Wellness (OTCMKTS:AYRWF - Get Free Report) and Trinity Biotech (NASDAQ: TRIB - Get Free Report)
- Agreement provides additional funding tool of up to $25 million over a period of up to 36 months -
DUBLIN, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage bio
DUBLIN, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage bio
DUBLIN, Ireland, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-
– Reinforces Trinity Biotech's growing position as a key player in diabetes care innovation – Senior
Trinity Biotech (NASDAQ: TRIB) surged on Tuesday due to a large HIV testing order and balance-sheet
Tuesday's session saw 729 companies set new 52-week lows.
Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday af
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Wednesday